Citius Pharmaceuticals, Inc.

CTXR - CIK 0001506251

Market cap-

Rank-

SEC filings625

CTXR income statement (quarterly)

The table below shows Citius Pharmaceuticals, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.

Line item	Q1 2026	Q4 2025	Q2 2025	Q1 2025	Q4 2024	Q2 2024
Revenue	$1.67M	$3.94M	-	-	-	-
Cost of revenue	$328.88K	$789.21K	-	-	-	-
Gross profit	$1.34M	$3.15M	-	-	-	-
R&D	$1.63M	$1.60M	$1.62M	$3.77M	$2.13M	$2.76M
SG&A

CTXR annual revenue (10-K history)

Citius Pharmaceuticals, Inc. reported annual revenue of $90.00K for fiscal year 2022. That is up 0.0% from $90.00K in fiscal 2021. Figures come from the company's audited annual reports as filed with the SEC.

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.